These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4631713)

  • 1. Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys.
    Katchen B; Buxbaum S; Meyer J; Ning J
    J Pharmacol Exp Ther; 1973 Feb; 184(2):453-64. PubMed ID: 4631713
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of clonixin (2-(3-chloro-o-toluidino) nicotinic acid) in humans.
    Katchen B; Buxbaum S; Ning J
    J Pharmacol Exp Ther; 1973 Oct; 187(1):152-7. PubMed ID: 4200989
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of C14-ICI 54,450 (myalex) in various species--an in vivo NIH shift.
    Foulkes DM
    J Pharmacol Exp Ther; 1970 Mar; 172(1):115-21. PubMed ID: 4984667
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; White SD; Rhodes RE; Arison BH; Umbenhauer ER; Bower RJ; McMahon FG
    Drug Metab Dispos; 1973; 1(6):721-36. PubMed ID: 4156293
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. 3. Species differences in metabolism.
    Tanayama S
    Xenobiotica; 1973 Oct; 3(10):671-80. PubMed ID: 4774633
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug.
    Noda K; Noguchi H; Okui M; Tada K; Morimoto Y
    Arzneimittelforschung; 1972 Apr; 22(4):732-43. PubMed ID: 4626080
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution, excretion metabolism and localization of a new anti-inflammatory drug: niflumic acid, labelled with 14C.
    Glasson B; Benakis A; Strolin-Benedetti M
    Biochem Pharmacol; 1969 Mar; 18(3):633-43. PubMed ID: 5772593
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
    Goldaniga GC; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolism of niflumic acid in man].
    Boissier JR; Tillement JP; Larousse C
    Therapie; 1971; 26(1):211-8. PubMed ID: 5554765
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. I. Absorption, distribution and excretion in rats.
    Tanayama S; Tsuchida E; Suzuoki Z
    Xenobiotica; 1973 Oct; 3(10):643-56. PubMed ID: 4774631
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
    [No Abstract]   [Full Text] [Related]  

  • 12. Some aspects of sorbinicate pharmacokinetics.
    Subissi A; Biagi M; Murmann W
    Arzneimittelforschung; 1980; 30(8):1278-84. PubMed ID: 7192142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fentiazac in rats and monkeys.
    Zanolo G; Giachetti C; Mondino A; Silvestri S; Bianchi E; Segre G; Gomarasca P; De Marchi G
    Arzneimittelforschung; 1981; 31(7):1098-104. PubMed ID: 7196759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. II. Isolation and identification of metabolites in the perfusate of the isolated liver perfusion in rats.
    Kanai Y; Kobayashi T; Tanayama S
    Xenobiotica; 1973 Oct; 3(10):657-70. PubMed ID: 4774632
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-nociceptive activity of clonixin in rhesus monkeys.
    Ciofalo VB; Patel J; Taber RI
    Jpn J Pharmacol; 1972 Dec; 22(6):749-53. PubMed ID: 4197784
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    ; ; . PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.